NCT07293247
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
At risk: Primary completion moved 4 years later.
See at-risk trials from Alliance for Clinical Trials in Oncology
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 9 versions: 8 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Minor Trial sites expanded: 111 → 125 locations
- Notable Primary completion pushed from Dec 31, 2028 to Dec 31, 2032
- Study completion pushed from Mar 1, 2032 to Mar 1, 2036
- Notable Eligibility criteria expanded, about 22 words
- Trial sites expanded: 97 → 111 locations
- Secondary endpoints: details revised at 4 of 4 entries
- Study description revised
- Notable Start date: Jul 14, 2026 to Oct 14, 2026
- Trial sites expanded: 74 → 97 locations
- Minor Trial sites expanded: 33 → 74 locationsv5
- Minor Trial sites expanded: 28 → 33 locationsv4
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date: Mar 14, 2026 to Jul 14, 2026
- Study sites: 0 to 28
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (4)
Arms and interventions
Patients receive SOC chemotherapy or immunotherapy on study. Treatment continues in the absence of disease progression or unacceptable toxicity. Patients also undergo CT and/or MRI, FDG-PET, and blood sample collection throughout the study.
Patients undergo I²-PORT QD Monday through Friday over 15-25 fractions over 5-6 weeks. Starting 1-42 days after completion of I²-PORT, patients receive SOC chemotherapy or immunotherapy on study. Treatment continues in the absence of disease progression or unacceptable toxicity. Patients also undergo CT and/or MRI, FDG-PET, and blood sample collection throughout the study.
Drugs: Chemotherapy
Other: Immunotherapy, Fludeoxyglucose F-18
Radiation: Intensity-Modulated Radiation Therapy
Procedures: Computed Tomography, Magnetic Resonance Imaging, Biospecimen Collection
Sites
125 sites in 1 country